Pablo Legorreta
Directeur Général chez RP Management LLC (Investment Management)
Profil
Mr. Pablo Legorreta is a Founder & Chief Executive Officer at RP Management LLC.
He has over 20 years of experience investing in pharmaceutical royalties, and building and managing a rapidly growing life sciences investment company that is today one of the largest dedicated life sciences investors in the world.
Prior to founding Royalty Pharma in 1996, Mr. Legorreta was an investment banker at Lazard Frères in Paris and New York.
Mr. Legorreta is also a co-founder of Pharmakon Advisors, a leading provider of debt capital to the life sciences industry.
He has a degree in industrial engineering from Universidad Iberoamericana in Mexico City.
He serves on the Board of Directors of Epizyme (Nasdaq: EPZM) and on the Board of Governors of the New York Academy of Sciences, as well as the Boards of Trustees of Rockefeller University, Brown University, the Hospital for Special Surgery, Pasteur Foundation (the U.S.
affiliate of the French Institute Pasteur), Open Medical Institute and Park Avenue Armory.
Postes actifs de Pablo Legorreta
| Sociétés | Poste | Début |
|---|---|---|
RP Management LLC (Investment Management)
 RP Management LLC (Investment Management) Investment ManagersFinance RP Management LLC (Investment Management) (RPM-IM) is the investment management division of RP Management LLC headquartered in New York and was founded in 2003. RPM-IM provides investment advice. They invest in marketed and late stage biopharmaceutical products. | Directeur Général | 01/01/2003 |
Formation de Pablo Legorreta
| Universidad Iberoamericana | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
RP Management LLC (Investment Management)
RP Management LLC (Investment Management) Investment ManagersFinance RP Management LLC (Investment Management) (RPM-IM) is the investment management division of RP Management LLC headquartered in New York and was founded in 2003. RPM-IM provides investment advice. They invest in marketed and late stage biopharmaceutical products. | Finance |